nav emailalert searchbtn searchbox tablepage yinyongbenwen piczone journalimg journalInfo journalinfonormal searchdiv searchzone qikanlogo popupnotification paper paperNew
2022, 03, v.41 659-670
精神疾病与酒精饮用的因果关联:两样本孟德尔随机化分析
基金项目(Foundation): 国家自然科学基金(U1804284,32070679); 国家重点研发计划(2016YFC1306903); 上海市精神病重点实验室课题(13dz2260500)共同资助
邮箱(Email): pandun@sjtu.edu.cn;shiyongyong@gmail.com;
DOI: 10.13417/j.gab.041.000659
发布时间: 2022-03-25
出版时间: 2022-03-25
移动端阅读
摘要:

科学研究表明精神疾病与饮酒具有较强的关联性,但这种关联的具体影响仍未被清楚地揭示。为了促进公共卫生的发展和临床干预治疗的进行,我们试图探讨精神疾病与饮酒的因果关系。基于全基因组关联性研究的最新公开统计数据,我们进行了两样本孟德尔随机化分析。研究对象涉及5种主要精神障碍(重度抑郁症,双相情感障碍,精神分裂症,自闭症谱系障碍,注意力缺陷多动障碍)以及酒精饮用(酒精依赖,酒精问题和每天饮酒次数)。主要分析方法为逆方差加权、MR-Egger回归分析、加权中位数分析以及MR-PRESSO,被进一步用作敏感性分析。我们发现了精神分裂症与酒精依赖(IVW beta=0.158 5,95%CI在0.058 4~0.258 7,P=0.001 9)和每天饮酒次数(IVW beta=-0.013 14,95%CI在-0.021 87~-0.004 417,P=0.003 2)之间存在因果关联。另外,自闭症谱系障碍(IVW beta=0.425 9, 95%CI在-0.784 8~-0.067 05,P=0.020)和注意力缺陷多动障碍(IVW beta=0.225 7, 95%CI在0.023 83~0.427 5,P=0.028)对酒精依赖也存在潜在的因果关联。我们的结果表明了精神分裂症和注意力缺陷多动障碍会增加酒精依赖的风险,同时也揭示精神分裂症与酒精饮用之间的因果关系,以及从自闭症谱系障碍和注意力缺陷多动障碍对于酒精使用的潜在因果关系。

Abstract:

Several mental disorders have consistently been found high likelihood to co-occur with alcohol use, but the nature of such association is still an unresolved issue. To facilitate public health and the intervention procedure for clinical treatment, the main question we are trying to answer is whether there is a causal effect of alcohol use on mental disease. We applied two-sample Mendelian randomization(MR) analysis, using the newest publicly available summary statistics from genome-wide association studies(GWAS) on five major mental disorders, including major depressive disorders(MDD), bipolar disorders(BPD), schizophrenia(SCZ), autism spectrum disorder(ASD), attention-deficit hyperactivity disorder(ADHD) and alcohol use(alcohol dependence, alcohol problems, and drinks per day). The analyzing method was inverse-variance weighted(IVW). MR-Egger regression and weighted median(WM) analyses were further used as sensitivity analyses. We found evidence for significant causal effects of SCZ on alcohol dependence(IVW beta =0.158 5, 95% CI, 0.058 4 to 0.258 7, P=0.001 9), and on drinks per day(IVW beta=-0.013 14, 95% CI,-0.021 87 to-0.004 417, P=0.003 2). We also found suggestive causal evidence for ASD(IVW beta=0.425 9, 95% CI-0.784 8 to-0.067 05, P=0.020) on alcohol dependence and ADHD(IVW beta=0.225 7, 95% CI 0.023 83 to 0.427 5, P =0.028) on alcohol dependence. Our findings strongly suggested SCZ and ADHD would increase the risk of alcohol dependence. Besides, the study also unraveled the causal relationships from SCZ to alcohol use and tentatively from ASD and ADHD to alcohol use.

参考文献

Aliyev N.A.,and Aliyev Z.N.,2005,Application of glycine in acute alcohol hallucinosis,Hum.Psychophar-macol.,20(8):591-594.

Allman P.H.,Aban I.B.,Tiwari H.K.,and Cutter G.R.,2018,An introduction to Mendelian randomization with applications in neurology,Mult.Scler.Relat.Disord.,24:72-78.

Bowden J.,Davey Smith G.,and Burgess S.,2015,Mendelian randomization with invalid instruments:effect estimation and bias detection through Egger regression,Int.J.Epidemiol.,44(2):512-525.

Bowden J.,and Holmes M.V.,2019,Meta-analysis and Mendelian randomization:a review,Res.Synth.Methods,10(4):486-496.

Burgess S.,Butterworth A.,and Thompson S.G.,2013,Mendelian randomization analysis with multiple genetic variants using summarized data,Genet.Epidemiol.,37(7):658-665.

Chambers R.A.,Krystal J.H.,and Self D.W.,2001,A neurobiological basis for substance abuse comorbidity in schizophrenia,Biol.Psychiatry,50(2):71-83.

Cheah S.Y.,Lawford B.R.,Young R.M.,Connor J.P.,Phillip-Morris C.,and Voisey J.,2014,BDNF SNPs are implicated in comorbid alcohol dependence in schizophrenia but not in alcohol-dependent patients without schizophrenia,Alcohol Alcohol.,49(5):491-497.

Clarke T.K.,Adams M.J.,Davies G.,Howard D.M.,Hall L.S.,Padmanabhan S.,Murray A.D.,Smith B.H.,Campbell A.,Hayward C.,Porteous D.J.,Deary I.J.,and McIntosh A.M.,2017,Genome-wide association study of alcohol consumption and genetic overlap with other health-related traits in UK Biobank (N=112 117),Mol.Psychiatry,22:1376-1384.

Demontis D.,Walters R.K.,Martin J.,Mattheisen M.,Als T.D.,Agerbo E.,Baldursson G.,Belliveau R.,Bybjerg-Grauholm J.,B?kvad-Hansen M.,Cerrato F.,Chambert K.,Churchhouse C.,Dumont A.,Eriksson N.,Gandal M.,Goldstein J.I.,Grasby K.L.,Grove J.,Gudmundsson O.O.,Hansen C.S.,Hauberg M.E.,Hollegaard M.V.,Howrigan D.P.,Huang H.,Maller J.B.,Martin A.R.,Martin N.G.,Moran J.,Pallesen J.,Palmer D.S.,Pedersen C.B.,Pedersen M.G.,Poterba T.,Poulsen J.B.,Ripke S.,Robinson E.B.,Satterstrom F.K.,Stefansson H.,Stevens C.,Turley P.,Walters G.B.,Won H.,Wright M.J.,Andreassen O.A.,Asherson P.,Burton C.L.,Boomsma D.I.,Cormand B.,Dalsgaard S.,Franke B.,Gelernter J.,Geschwind D.,Hakonarson H.,Haavik J.,Kranzler H.R.,Kuntsi J.,Langley K.,Lesch K.P.,Middeldorp C.,Reif A.,Rohde L.A.,Roussos P.,Schachar R.,Sklar P.,Sonuga-Barke E.J.S.,Sullivan P.F.,Thapar A.,Tung J.Y.,Waldman I.D.,Medland S.E.,Stefansson K.,Nordentoft M.,Hougaard D.M.,Werge T.,Mors O.,Mortensen P.B.,Daly M.J.,Faraone S.V.,B?rglum A.D.,and Neale B.M.,2019,Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder,Nat.Genet.,51(1):63-75.

Fadda F.,Mosca E.,Colombo G.,and Gessa G.L.,1989,Effect of spontaneous ingestion of ethanol on brain dopamine metabolism,Life Sci.,44(4):281-287.

Green A.I.,Drake R.E.,Brunette M.F.,and Noordsy D.L.,2007,Schizophrenia and co-occurring substance use disorder,Am.J.Psychiatry,164(3):402-408.

Hemani G.,Zheng J.,Elsworth B.,Wade K.H.,Haberland V.,Baird D.,and Haycock P.C.,2018,The MR-base platform supports systematic causal inference across the human phenome,Elife,7:e34408.

Howard D.M.,Adams M.J.,Clarke T.K.,Hafferty J.D.,Gibson J.,Shirali M.,Coleman J.R.I.,Hagenaars S.P.,Ward J.,Wigmore E.M.,Alloza C.,Shen X.Y.,Barbu M.C.,Xu E.Y.,Whalley H.C.,Marioni R.E.,Porteous D.J.,Davies G.,Deary I.J.,Hemani G.,Berger K.,Teismann H.,Rawal R.,Arolt V.,Baune B.T.,Dannlowski U.,Domschke K.,Tian C.,Hinds D.A.,23andMe Research Team,Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium,Trzaskowski M.,Byrne E.M.,Ripke S.,Smith D.J.,Sullivan P.F.,Wray N.R.,Breen G.,Lewis C.M.,and McIntosh A.M.,2019,Genome-wide meta-analysis of depression identifies 102 independent variants and highlights the importance of the prefrontal brain regions,Nat.Neurosci.,22(3):343-352.

Hunt G.E.,Large M.M.,Cleary M.,Lai H.M.X.,and Saunders J.B.,2018,Prevalence of comorbid substance use in schizophrenia spectrum disorders in community and clinical settings,1990~2017:Systematic review and meta-analysis,Drug Alcohol Depend.,191:234-258.

Ira E.,Zanoni M.,Ruggeri M.,Dazzan P.,and Tosato S.,2013,COMT,neuropsychological function and brain structure in schizophrenia:a systematic review and neurobiological interpretation,J.Psychiatry Neurosci.,38(6):366-380.

Ivanov H.Y.,Stoyanova V.K.,Popov N.T.,and Vachev T.I.,2015,Autism spectrum disorder-a complex genetic disorder,Folia Med.(Plovdiv),57(1):19-28.

Jordaan G.P.,and Emsley R.,2014,Alcohol-induced psychotic disorder:a review,Metab.Brain Dis.,29(2):231-243.

Khokhar J.Y.,Dwiel L.L.,Henricks A.M.,Doucette W.T.,and Green A.I.,2018,The link between schizophrenia and substance use disorder:a unifying hypothesis,Schizophr.Res.,194:78-85.

Liu M.Z.,Jiang Y.,Wedow R.,Li Y.,Brazel D.M.,Chen F.,Datta G.,Davila-Velderrain J.,McGuire D.,Tian C.,Zhan X.W.,23andMe Research Team,HUNT All-in Psychiatry,Choquet H.,Docherty A.R.,Faul J.D.,Foerster J.R.,Fritsche L.G.,Gabrielsen M.E.,Gordon S.D.,Haessler J.,Hottenga J.J.,Huang H.Y.,Jang S.K.,Jansen P.R.,Ling Y.,M?gi R.,Matoba N.,McMahon G.,Mulas A.,Orrù V.,Palviainen T.,Pandit A.,Reginsson G.W.,Skogholt A.H.,Smith J.A.,Taylor A.E.,Turman C.,Willemsen G.,Young H.,Young K.A.,Zajac G.J.M.,Zhao W.,Zhou W.,Bjornsdottir G.,Boardman J.D.,Boehnke M.,Boomsma D.I.,Chen C.,Cucca F.,Davies G.E.,Eaton C.B.,Ehringer M.A.,Esko T.,Fiorillo E.,Gillespie N.A.,Gudbjartsson D.F.,Haller T.,Harris K.M.,Heath A.C.,Hewitt J.K.,Hickie I.B.,Hokanson J.E.,Hopfer C.J.,Hunter D.J.,Iacono W.G.,Johnson E.O.,Kamatani Y.,Kardia S.L.R.,Keller M.C.,Kellis M.,Kooperberg C.,Kraft P.,Krauter K.S.,Laakso M.,Lind P.A.,Loukola A.,Lutz S.M.,Madden P.A.F.,Martin N.G.,McGue M.,McQueen M.B.,Medland S.E.,Metspalu A.,Mohlke K.L.,Nielsen J.B.,Okada Y.,Peters U.,Polderman T.J.C.,Posthuma D.,Reiner A.P.,Rice J.P.,Rimm E.,Rose R.J.,Runarsdottir V.,Stallings M.C.,Stan■áková A.,Stefansson H.,Thai K.K.,Tindle H.A.,Tyrfingsson T.,Wall T.L.,Weir D.R.,Weisner C.,Whitfield J.B.,Winsvold B.S.,Yin J.,Zuccolo L.,Bierut L.J.,Hveem K.,Lee J.J.,Munafò M.R.,Saccone N.L.,Willer C.J.,Cornelis M.C.,David S.P.,Hinds D.A.,Jorgenson E.,Kaprio J.,Stitzel J.A.,Stefansson K.,Thorgeirsson T.E.,Abecasis G.,Liu D.J.,and Vrieze S.,2019,Association studies of up to 1.2 million individuals yield new insights into the genetic etiology of tobacco and alcohol use,Nat.Genet.,51(2):237-244.

Martinowich K.,Schloesser R.J.,and Manji H.K.,2009,Bipolar disorder:from genes to behavior pathways,J.Clin.Invest.,119(4):726-736.

Matoba N.,Liang D.,Sun H.G.,Aygün N.,McAfee J.C.,Davis J.E.,Raffield L.M.,Qian H.J.,Piven J.,Li Y.,Kosuri S.,Won H.,and Stein J.L.,2020,Common genetic risk variants identified in the SPARK cohort support DDHD2 as a candidate risk gene for autism,Transl.Psychiatry,10(1):265.

Mochrie K.D.,Whited M.C.,Cellucci T.,Freeman T.,and Corson A.T.,2020,ADHD,depression,and substance abuse risk among beginning college students,J.Am.Coll.Health,68(1):6-10.

Mueser K.T.,and McGurk S.R.,2004,Schizophrenia,Lancet.,363(9426):2063-2072.

Müller J.K.,and Leweke F.M.,2016,Bipolar disorder:clinical overview,Med.Monatsschr.Pharm.,39(9):363-369.

Polimanti R.,Peterson R.E.,Ong J.S.,MacGregor S.,Edwards A.C.,Clarke T.K.,Frank J.,Gerring Z.,Gillespie N.A.,Lind P.A.,Maes H.H.,Martin N.G.,Mbarek H.,Medland S.E.,Streit F.,Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium,Agrawal A.,Edenberg H.J.,Kendler K.S.,Lewis C.M.,Sullivan P.F.,Wray N.R.,Gelernter J.,and Derks E.M.,2019,Evidence of causal effect of major depression on alcohol dependence:findings from the psychiatric genomics consortium,Psychol.Med.,49(7):1218-1226.

Rakofsky J.,and Rapaport M,2018,Mood disorders,continuum (Minneap Minn),Behavioral Neurology and Psychiatry,24(3):804-827.

Rees J.M.B.,Wood A.M.,and Burgess S.,2017,Extending the MR-Egger method for multivariable Mendelian randomization to correct for both measured and unmeasured pleiotropy,Stat.Med.,36(29):4705-4718.

Regier D.A.,Farmer M.E.,Rae D.S.,Locke B.Z.,Keith S.J.,Judd L.L.,and Goodwin F.K.,1990,Comorbidity of mental disorders with alcohol and other drug abuse.Results from the Epidemiologic Catchment Area (ECA) Study,JAMA,264(19):2511-2518.

Ripke S.,Walters J.T.,and O′Donovan M.C,2020,Mapping genomic loci prioritises genes and implicates synaptic biology in schizophrenia,MedRxiv,doi:10.1101/2020.09.12.20192922.

Roick C.,Fritz-Wieacker A.,Matschinger H.,Heider D.,Schindler J.,Riedel-Heller S.,and Angermeyer M.C.,2007,Health habits of patients with schizophrenia,Soc.Psychiatry Psychiatr.Epidemiol.,42(4):268-276.

Sanchez-Roige S.,Palmer A.A.,Fontanillas P.,Elson S.L.,the Substance Use Disorder Working Group of the Psychiatric Genomics Consortium,23 and Me Research Team,Adams M.J.,Howard D.M.,Edenberg H.J.,Davies G.,Crist R.C.,Deary I.J.,McIntosh A.M.,and Clarke T.K.,2019,Genome-wide association study meta-analysis of the alcohol use disorders identification test (AUDIT) in two population-based cohorts,Am.J.Psychiatry,176(2):107-118.

Sharma A.,and Couture J.,2014,A review of the pathophysiology,etiology,and treatment of attention-deficit hyperactivity disorder (ADHD),Ann.Pharmacother.,48(2):209-225.

Stahl E.A.,Breen G.,Forstner A.J.,McQuillin A.,Ripke S.,Trubetskoy V.,Mattheisen M.,Wang Y.,Coleman J.R.I.,Gaspar H.A.,de Leeuw C.A.,Steinberg S.,Pavlides J.M.W.,Trzaskowski M.,Byrne E.M.,Pers T.H.,Holmans P.A.,Richards A.L.,Abbott L.,Agerbo E.,Akil H.,Albani D.,Alliey-Rodriguez N.,Als T.D.,Anjorin A.,Antilla V.,Awasthi S.,Badner J.A.,B?kvad-Hansen M.,Barchas J.D.,Bass N.,Bauer M.,Belliveau R.,Bergen S.E.,Pedersen C.B.,B?en E.,Boks M.P.,Boocock J.,Budde M.,Bunney W.,Burmeister M.,Bybjerg-Grauholm J.,Byerley W.,Casas M.,Cerrato F.,Cervantes P.,Chambert K.,Charney A.W.,Chen D.,Churchhouse C.,Clarke T.K.,Coryell W.,Craig D.W.,Cruceanu C.,Curtis D.,Czerski P.M.,Dale A.M.,de Jong S.,Degenhardt F.,Del-Favero J.,DePaulo J.R.,Djurovic S.,Dobbyn A.L.,Dumont A.,Elvs?shagen T.,Escott-Price V.,Fan C.C.,Fischer S.B.,Flickinger M.,Foroud T.M.,Forty L.,Frank J.,Fraser C.,Freimer N.B.,Frisén L.,Gade K.,Gage D.,Garnham J.,Giambartolomei C.,Pedersen M.G.,Goldstein J.,Gordon S.D.,Gordon-Smith K.,Green E.K.,Green M.J.,Greenwood T.A.,Grove J.,Guan W.,Guzman-Parra J.,Hamshere M.L.,Hautzinger M.,Heilbronner U.,Herms S.,Hipolito M.,Hoffmann P.,Holland D.,Huckins L.,Jamain S.,Johnson J.S.,Juréus A.,Kandaswamy R.,Karlsson R.,Kennedy J.L.,Kittel-Schneider S.,Knowles J.A.,Kogevinas M.,Koller A.C.,Kupka R.,Lavebratt C.,Lawrence J.,Lawson W.B.,Leber M.,Lee P.H.,Levy S.E.,Li J.Z.,Liu C.,Lucae S.,Maaser A.,MacIntyre D.J.,Mahon P.B.,Maier W.,Martinsson L.,McCarroll S.,McGuffin P.,McInnis M.G.,McKay J.D.,Medeiros H.,Medland S.E.,Meng F.,Milani L.,Montgomery G.W.,Morris D.W.,Mühleisen T.W.,Mullins N.,Nguyen H.,Nievergelt C.M.,Adolfsson A.N.,Nwulia E.A.,O'Donovan C.,Loohuis L.M.O.,Ori A.P.S.,Oruc L.,?sby U.,Perlis R.H.,Perry A.,Pfennig A.,Potash J.B.,Purcell S.M.,Regeer E.J.,Reif A.,Reinbold C.S.,Rice J.P.,Rivas F.,Rivera M.,Roussos P.,Ruderfer D.M.,Ryu E.,Sánchez-Mora C.,Schatzberg A.F.,Scheftner W.A.,Schork N.J.,Shannon Weickert C.,Shehktman T.,Shilling P.D.,Sigurdsson E.,Slaney C.,Smeland O.B.,Sobell J.L.,S?holm Hansen C.,Spijker A.T.,St Clair D.,Steffens M.,Strauss J.S.,Streit F.,Strohmaier J.,Szelinger S.,Thompson R.C.,Thorgeirsson T.E.,Treutlein J.,Vedder H.,Wang W.,Watson S.J.,Weickert T.W.,Witt S.H.,Xi S.,Xu W.,Young A.H.,Zandi P.,Zhang P.,Z?llner S.,eQTLGen Consortium;BIOS Consortium,Adolfsson R.,Agartz I.,Alda M.,Backlund L.,Baune B.T.,Bellivier F.,Berrettini W.H.,Biernacka J.M.,Blackwood D.H.R.,Boehnke M.,B?rglum A.D.,Corvin A.,Craddock N.,Daly M.J.,Dannlowski U.,Esko T.,Etain B.,Frye M.,Fullerton J.M.,Gershon E.S.,Gill M.,Goes F.,Grigoroiu-Serbanescu M.,Hauser J.,Hougaard D.M.,Hultman C.M.,Jones I.,Jones L.A.,Kahn R.S.,Kirov G.,Landén M.,Leboyer M.,Lewis C.M.,Li Q.S.,Lissowska J.,Martin N.G.,Mayoral F.,McElroy S.L.,McIntosh A.M.,McMahon F.J.,Melle I.,Metspalu A.,Mitchell P.B.,Morken G.,Mors O.,Mortensen P.B.,Müller-Myhsok B.,Myers R.M.,Neale B.M.,Nimgaonkar V.,Nordentoft M.,N?then M.GM.,O′Donovan M.C.,Oedegaard K.J.,Owen M.J.,Paciga S.A.,Pato C.,Pato M.T.,Posthuma D.,Ramos-Quiroga J.A.,Ribasés M.,Rietschel M.,Rouleau G.A.,Schalling M.,Schofield P.R.,Schulze T.G.,Serretti A.,Smoller J.W.,Stefansson H.,Stefansson K.,Stordal E.,Sullivan P.F.,Turecki G.,Vaaler A.E.,Vieta E.,Vincent J.B.,Werge T.,Nurnberger J.I.,Wray N.R.,Di Florio A.,Edenberg H.J.,Cichon S.,Ophoff R.A.,Scott L.J.,Andreassen O.A.,Kelsoe J.,Sklar P.,Bipolar Disorder Working Group of the Psychiatric Genomics Consortium,2019,Genome-wide association study identifies 30 loci associated with bipolar disorder,Nat.Genet.,51(5):793-803.

Stein D.J.,2013,What is a mental disorder?A perspective from cognitive-affective science,Can.J.Psychiatry,58(12):656-662.

Sudhinaraset M.,Wigglesworth C.,and Takeuchi D.T.,2016,Social and cultural contexts of alcohol use:Influences in a social-ecological framework,Alcohol Res.,38(1):35-45.

Tandon M.,and Pergjika A.,2017,Attention deficit hyperactivity disorder in preschool-age children,Child Adolesc.Psychiatr.Clin.N.Am.,26(3):523-538.

Thapar A.,Cooper M.,and Rutter M,2017,Neurodevelopmental disorders,Lancet Psychiat.,4(4):339-346.

Thompson T.P.,Taylor A.H.,Wanner A.,Husk K.,Wei Y.,Creanor S.,and Wallace G,2018,Physical activity and the prevention,reduction,and treatment of alcohol and/or substance us across the lifespan(The PHASE review):protoclo for a systematic review,Syst.Rev.,7(1):9.

Treur J.L.,Demontis D.,Smith G.D.,Sallis H.,Richardson T.G.,Wiers R.W.,B?rglum A.D.,Verweij K.J.H.,and Munafò M.R.,2021,Investigating causality between liability to ADHD and substance use,and liability to substance use and ADHD risk,using Mendelian randomization,Addict.Biol.,26(1):e12849.

Verbanck M.,Chen C.Y.,Neale B.,and Do R.,2018,Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases,Nat.Genet.,50(5):693-698.

Walters R.K.,Polimanti R.,Johnson E.C.,McClintick J.N.,Adams M.J.,Adkins A.E.,Aliev F.,Bacanu S.A.,Batzler A.,Bertelsen S.,Biernacka J.M.,Bigdeli T.B.,Chen L.S.,Clarke T.K.,Chou Y.L.,Degenhardt F.,Docherty A.R.,Edwards A.C.,Fontanillas P.,Foo J.C.,Fox L.,Frank J.,Giegling I.,Gordon S.,Hack L.M.,Hartmann A.M.,Hartz S.M.,Heilmann-Heimbach S.,Herms S.,Hodgkinson C.,Hoffmann P.,Hottenga J.J.,Kennedy M.A.,Alanne-Kinnunen M.,Konte B.,Lahti J.,Lahti-Pulkkinen M.,Lai D.B.,Ligthart L.,Loukola A.,Maher B.S.,Mbarek H.,McIntosh A.M.,McQueen M.B.,Meyers J.L.,Milaneschi Y.,Palviainen T.,Pearson J.F.,Peterson R.E.,Ripatti S.,Ryu E.,Saccone N.L.,Salvatore J.E.,Sanchez-Roige S.,Schwandt M.,Sherva R.,Streit F.,Strohmaier J.,Thomas N.,Wang J.C.,Webb B.T.,Wedow R.,Wetherill L.,Wills A.G.,23andMe Research Team,Boardman J.D.,Chen D.F.,Choi D.S.,Copeland W.E.,Culverhouse R.C.,Dahmen N.,Degenhardt L.,Domingue B.W.,Elson S.L.,Frye M.A.,G?bel W.,Hayward C.,Ising M.,Keyes M.,Kiefer F.,Kramer J.,Kuperman S.,Lucae S.,Lynskey M.T.,Maier W.,Mann K.,M?nnist? S.,Müller-Myhsok B.,Murray A.D.,Nurnberger J.I.,Palotie A.,Preuss U.,R?ikk?nen K.,Reynolds M.D.,Ridinger M.,Scherbaum N.,Schuckit M.A.,Soyka M.,Treutlein J.,Witt S.,Wodarz N.,Zill P.,Adkins D.E.,Boden J.M.,Boomsma D.I.,Bierut L.J.,Brown S.A.,Bucholz K.K.,Cichon S.,Costello E.J.,De Wit H.,Diazgranados N.,Dick D.M.,Eriksson J.G.,Farrer L.A.,Foroud T.M.,Gillespie N.A.,Goate A.M.,Goldman D.,Grucza R.A.,Hancock D.B.,Harris K.M.,Heath A.C.,Hesselbrock V.,Hewitt J.K.,Hopfer C.J.,Horwood J.,Iacono W.,Johnson E.O.,Kaprio J.A.,Karpyak V.M.,Kendler K.S.,Kranzler H.R.,Krauter K.,Lichtenstein P.,Lind P.A.,McGue M.,MacKillop J.,Madden P.A.F.,Maes H.H.,Magnusson P.,Martin N.G.,Medland S.E.,Montgomery G.W.,Nelson E.C.,N?then M.M.,Palmer A.A.,Pedersen N.L.,Penninx B.W.J.H.,Porjesz B.,Rice J.P.,Rietschel M.,Riley B.P.,Rose R.,Rujescu D.,Shen P.H.,Silberg J.,Stallings M.C.,Tarter R.E.,Vanyukov M.M.,Vrieze S.,Wall T.L.,Whitfield J.B.,Zhao H.Y.,Neale B.M.,Gelernter J.,Edenberg H.J.,and Agrawal A.,2018,Transancestral GWAS of alcohol dependence reveals common genetic underpinnings with psychiatric disorders,Nat.Neurosci.,21(12):1656-1669.

World Health Organization,2018,Global status report on alcohol and health,https://www.who.int/zh/news-room/fact-sheets/detail/alcohol.

Wray N.R.,Ripke S.,Mattheisen M.,Trzaskowski M.,Byrne E.M.,Abdellaoui A.,and Sullivan P.F,2018,Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression,Nat.Genet.,50(5):668-681.

基本信息:

DOI:10.13417/j.gab.041.000659

中图分类号:R749

引用信息:

[1]范佳慧,Syed Ali Alamdar Shah,温燕勤,等.精神疾病与酒精饮用的因果关联:两样本孟德尔随机化分析[J].基因组学与应用生物学,2022,41(03):659-670.DOI:10.13417/j.gab.041.000659.

基金信息:

国家自然科学基金(U1804284,32070679); 国家重点研发计划(2016YFC1306903); 上海市精神病重点实验室课题(13dz2260500)共同资助

发布时间:

2022-03-25

出版时间:

2022-03-25

检 索 高级检索